EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Immunohistochemical Prognostic Value of Nuclear and Cytoplasmic Silent Information Regulator 1 Protein Expression in Saudi Patients with Breast Cancer

Bayan Alharbi, Alia Aldahlawi iD, Mourad Assidi iD, Fatemah Basingab iD, Kawther Zaher iD, Jehan Alrahimi iD, Sara Mokhtar, Jaudah Al-Maghrabi iD, Abdelbaset Buhmeida, Kaltoom Al-Sakkaf

Biomolecules · 2025

DOI: 10.3390/biom15010050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Bayan Alharbi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia. Hauptthemen laut MEDLINE: Sirtuin 1, Breast Neoplasms, Cytoplasm, Cell Nucleus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Deputyship for Research and Innovation, Ministry of Education, Saudi Arabia, Deputyship for Research and Innovation, Ministry of Education, Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The mammalian NAD-dependent deacetylase sirtuin-1 family (named also silent information regulator or SIRT family, where NAD stands for “nicotinamide adenine dinucleotide” (NAD)) appears to have a dual role in several human cancers by modulating cell proliferation and death. This study examines how SIRT1 protein levels correlate with clinicopathological characteristics and survival outcomes in patients with breast cancer.

Methods

A total of 407 BC formalin-fixed paraffin-embedded (FFPE) samples were collected from King Abdulaziz University Hospital, Saudi Arabia. SIRT1 was stained on tissue microarray slides using automated immunohistochemistry.

Results

All BC subtypes expressed more nuclear SIRT1 proteins than their cytoplasm counterparts. In luminal A, luminal B, and TNBC, nuclear and cytoplasmic SIRT1 were highly associated (p < 0.001). Kaplan–Meier analysis showed reduced disease-specific survival (DSS) in H2BC with high SIRT1 nuclear expression (p = 0.001, log-rank). Moreover, the cytoplasmic expression of SIRT1 in HER2-positive BC was associated with a larger tumor size (p = 0.036) and lymph node metastasis (p = 0.045). Nuclear SIRT1 expression was also positively associated with lymph node metastasis (LNM) (p = 0.048). As low-grade tumors had a higher frequency of SIRT1 protein expression than other groups, SIRT1 expression was associated with a favorable prognosis in patients with luminal A BC (p < 0.001).

Conclusions

SIRT1 expression seems to be involved in different molecular pathways either suppressing or promoting tumor growth depending on the subtype of BC. These molecular functions require further investigations and validation on larger BC cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sirtuin 1Breast NeoplasmsCytoplasmCell NucleusHumansFemaleSaudi ArabiaMiddle AgedPrognosisImmunohistochemistryAdultAgedBiomarkers, TumorKaplan-Meier Estimate

Stichwörter der Autor:innen

BC molecular subtypesbreast cancer (BC)immunohistochemistrysilent information regulator 1 (SIRT1)tissue microarray

Substanzen

Sirtuin 1SIRT1 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
  • Laboratory, King Salman Medical City, Madinah 42319, Saudi Arabia.
  • Department of Biological Sciences, Faculty of Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
  • Immunology Unit, King Fahad for Medical Research, King Abdul-Aziz University, Jeddah 21589, Saudi Arabia.
  • Institute of Genomic Medicine Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
  • Department of Pathology, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia.

ORCID-Profile: Alia Aldahlawi, Mourad Assidi, Fatemah Basingab, Kawther Zaher, Jehan Alrahimi, Jaudah Al-Maghrabi

Förderung

  • the Deputyship for Research and Innovation, Ministry of Education, Saudi Arabia
  • Deputyship for Research and Innovation, Ministry of Education, Saudi Arabia

Zitieren

APA

Alharbi, B., Aldahlawi, A., Assidi, M., Basingab, F., Zaher, K., Alrahimi, J., Mokhtar, S., Al-Maghrabi, J., Buhmeida, A., & Al-Sakkaf, K. (2025). The Immunohistochemical Prognostic Value of Nuclear and Cytoplasmic Silent Information Regulator 1 Protein Expression in Saudi Patients with Breast Cancer. Biomolecules. https://doi.org/10.3390/biom15010050

Vancouver

Alharbi B, Aldahlawi A, Assidi M, Basingab F, Zaher K, Alrahimi J, et al. The Immunohistochemical Prognostic Value of Nuclear and Cytoplasmic Silent Information Regulator 1 Protein Expression in Saudi Patients with Breast Cancer. Biomolecules. 2025. doi:10.3390/biom15010050

BibTeX
@article{Alharbi2025,
  author = {Alharbi, Bayan and Aldahlawi, Alia and Assidi, Mourad and Basingab, Fatemah and Zaher, Kawther and Alrahimi, Jehan and Mokhtar, Sara and Al-Maghrabi, Jaudah and Buhmeida, Abdelbaset and Al-Sakkaf, Kaltoom},
  title = {The Immunohistochemical Prognostic Value of Nuclear and Cytoplasmic Silent Information Regulator 1 Protein Expression in Saudi Patients with Breast Cancer},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15010050}
}
Kostenlos starten →